Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the August 14, 2014, Federal Register, FDA reopened the comment period for the draft guidance Best Practices in Developing Proprietary Names for Drugs.
United StatesFood, Drugs, Healthcare, Life Sciences
In the August 14, 2014, Federal Register, FDA reopened the
comment period for the draft guidance Best Practices in Developing Proprietary Names
for Drugs. The draft guidance was initially published in
the May 29, 2014, Federal Register. FDA reopened the
comment period in response to requests stating the original 60-day
comment period, which closed on July 28, 2014, did not allow
sufficient time to develop a meaningful or thoughtful response.
Comments due September 15, 2014.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
